An enterovirus vaccine developed in Taiwan has proved highly successful in the animal testing stage and is set to proceed to human clinical trials, a researcher at the National Health Research Institutes (NHRI) said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Taiwan to expand NHI coverage to include cancer immunotherapies
04/24/2025 06:35 PM - Culture
Premiere held for Taiwan's 1st North-South Pole nature doc
04/24/2025 06:12 PM - Business
Taiwan stock market opens higher but ends 0.82% lower
04/24/2025 05:59 PM - Politics
Taiwan FM, King, unveils oil reserve facility project in Eswatini
04/24/2025 05:42 PM - Society
Driver held for drug-related negligent injury after cycling collision
04/24/2025 05:14 PM